Form 4: Arcadia Biosciences CEO Thomas Schaefer Acquires Additional Shares Through Employee Stock Purchase Plan

Arcadia Biosciences CEO Thomas Schaefer purchased 700 shares of common stock at $2.06 per share through the company's Employee Stock Purchase Plan on August 1, 2024.

Summary

• On August 1, 2024, Thomas J. Schaefer, CEO of Arcadia Biosciences, Inc., acquired 700 shares of the company's common stock.
• The purchase was made through the company's 2015 Employee Stock Purchase Plan (ESPP) at a price of $2.06 per share.
• The price was determined as 85% of the closing price of Arcadia Biosciences' common stock, as per the ESPP terms.
• Following the transaction, Schaefer directly owns 2,119 shares of Arcadia Biosciences common stock, including ESPP purchases from February 1, 2021, to August 1, 2024.
• These ESPP transactions are exempt from Rule 16b-3(c).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase indicates confidence, but it's a small transaction through a standard employee program.

Positives

• The CEO's participation in the ESPP demonstrates confidence in the company's future.
• The ESPP provides employees with an opportunity to invest in the company's success.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's prospects. Purchases are generally viewed as a positive signal.

Comparison to Industry Standards

• Employee stock purchase plans are a common benefit offered by publicly traded companies to incentivize employee ownership.
• The discount of 15% (85% of closing price) offered through Arcadia Biosciences' ESPP is a fairly standard discount compared to other companies with similar plans.
• Comparing insider trading activity to peers like Calyxt (CLXT) or Benson Hill (BHIL) would provide a broader context, but this document focuses solely on a single transaction.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals management's confidence.
• Employees participating in the ESPP benefit from the discounted stock purchase.

Key Dates

Keywords

Arcadia Biosciences, RKDA, Thomas Schaefer, CEO, Employee Stock Purchase Plan, ESPP, Form 4, Insider Trading, Beneficial Ownership, Stock Purchase